The Weekly Insight: August 13

13th Aug 2018

Texas Insight’s Recent Reports

  • HHSC: Drug Utilization Review (DUR) Board: Meeting Highlights: 1. Elect chair; 2. Bylaws revision; 3. Report on HHSC decisions on acceptance of the DUR recommendations from the April 27, 2018, meeting; and 4. Public comment on drug classes and therapeutic and clinical drug reviews to be reviewed for the Medicaid PDL.
  • HHSC: Aging Texas Well Advisory Committee: The Advisory committee met to receive updates on the following: 1. HHSC has developed a health and specialty care system that encompasses the State Supported Living Centers and the state hospitals; 2. A presentation was delivered that looks at aging issues and the lessons-learned following Hurricane Harvey; 3. Divisions provided updates- almost all the divisions are being impacted by the brand-new information system that just rolled out; and 4. The SB 1693 Report is on track to meet the required September 1, 2018 deadline.
  • House Select Committee on Opioids & Substance Abuse: Charge 6: The Select Committee met on August 7 to consider Charge 6 and Charge 8. This report addresses only Charge 6: Examine the impact of substance abuse and substance use disorders on Texans who are involved in the adult or juvenile criminal justice system and/or the Child Protective Services system. Identify barriers to treatment and the availability of treatment in various areas of the state. Recommend solutions to improve state and local policy, including alternatives to justice system involvement, and ways to increase access to effective treatment and recovery options. Invited testimony only.
  • House Select Committee on Opioids and Substance Abuse: Public Testimony: The Select Committee met on August 8th to hear public testimony on all previously considered committee charges. Public testimony was limited to three (3) minutes. This was the 6th and final hearing of the Committee.

Looking Ahead

State and Federal Healthcare News